Cytochrome P450 and Vascular Homeostasis
Abstract
Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize arachidonic acid to substances which affect arterial tone, it has become increasingly clear that CYP enzymes expressed within the cardiovascular system play a crucial role in the modulation of vascular homeostasis. There is strong evidence suggesting that the activation of a CYP epoxygenase in endothelial cells is an essential step in nitric oxide and prostacyclin-independent vasodilatation of several vascular beds, particularly in the heart and kidney. A smooth muscle CYP ω-hydroxylase, on the other hand, generates a vasoconstrictor eicosanoid that is central to the myogenic response. Moreover, CYP epoxygenase and ω-hydroxylase products, as well as CYP-derived reactive oxygen species, are intracellular signal transduction molecules involved in several signaling cascades affecting numerous cellular processes, including vascular cell proliferation and angiogenesis. This review summarizes the vascular effects of epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid, both of which are CYP-derived metabolites of arachidonic acid, endogenously generated within endothelial and vascular smooth muscle cells. Although the link between CYP expression/activity and cardiovascular disease is currently tentative, the evidence being accumulated to suggest that CYP pathways are altered in animal models of hypertension and atherosclerosis can no longer be ignored. The development of selective pharmacological tools is, however, a prerequisite for the analysis of the involvement of specific CYP isoforms in the regulation of vascular homeostasis in human subjects.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The presence of CYPOR and CYP proteins in endothelial cells makes them a significant source of superoxide in the vasculature.
“The presence of these proteins in endothelial cells makes them a significant source of superoxide in the vasculature (295, 298).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cytochrome P-450: Structure, Mechanism, and Biochemistry
de Montellano, O., & Paul, R. (1986) · Medical Entomology and Zoology · Cited by 2,667 · see citing works
Signal Transduction through MAP Kinase Cascades
Lewis, T. S., Shapiro, P. S., & Ahn, N. G. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,746 · see citing works
On the local reactions of the arterial wall to changes of internal pressure
Bayliss, W. M. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000911 · Cited by 1,526 · see citing works
Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing Factors
Campbell, W. B., Gebremedhin, D., Pratt, P. F., & Harder, D. R. (1996) · Circulation Research · doi:10.1161/01.res.78.3.415 · Cited by 1,221 · see citing works
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X.-L., Yang, B., Spiecker, M., Ley, K. F., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,218 · see citing works
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fißlthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911 · see citing works
Self-citationGuengerich, F. P. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2391-5_14 · Cited by 727 · see citing works
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 591 · see citing works
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 559 · see citing works
Wolfrum, C., Borrmann, C. M., Börchers, T., & Spener, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051619898 · Cited by 503 · see citing works
Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., & Zeldin, D. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3460 · Cited by 473 · see citing works
Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids
Yu, Z., Xu, F., Huse, L. M., Morisseau, C. H. P., Draper, A. J., Newman, J. W. I., Parker, C. E., Graham, L., Engler, M. M., Hammock, B. D., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.11.992 · Cited by 469 · see citing works
Fleming, I., Michaelis, U. R., Bredenkötter, D., Fisslthaler, B., Dehghani, F., Brandes, R. P., & Busse, R. (2001) · Circulation Research · doi:10.1161/01.res.88.1.44 · Cited by 440 · see citing works
Self-citationNitric Oxide Attenuates the Release of Endothelium-Derived Hyperpolarizing Factor
Bauersachs, J. K., Popp, R., Hecker, M., Sauer, E., Fleming, I., & Busse, R. (1996) · Circulation · doi:10.1161/01.cir.94.12.3341 · Cited by 430 · see citing works
Self-citationHecker, M., Bara, A. T., Bauersachs, J. K., & Busse, R. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020449 · Cited by 418 · see citing works
Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation
Sinal, C. J., Miyata, M., Tohkin, M., Nagata, K., Bend, J. R., & Gonzalez, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m008106200 · Cited by 341 · see citing works
Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase
Schwartzman, M. L., Ferreri, N. R., Carroll, M. A., Songu‐Mize, E., & McGiff, J. C. (1985) · Nature · doi:10.1038/314620a0 · Cited by 309 · see citing works
Signaling by dual specificity kinases
Dhanasekaran, N., & Reddy, E. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202251 · Cited by 304 · see citing works
Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine
Rudas, L., Crossman, A. A., Morillo, C. A., Halliwill, J. R., Tahvanainen, K. U. O., Kuusela, T., & Eckberg, D. L. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.5.h1691 · Cited by 295 · see citing works
Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid.
Capdevila, J. H., Chacos, N., Werringloer, J., Prough, R. A., & Estabrook, R. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5362 · Cited by 292 · see citing works
High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors.
Álvarez, J., Montero, M., & Garcı́a-Sancho, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49767-6 · Cited by 282 · see citing works
Yang, B., Graham, L., Dikalov, S., Mason, R. P., Falck, J. R., Liao, J. K., & Zeldin, D. C. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.310 · Cited by 266 · see citing works
Li, P., & Campbell, W. B. (1997) · Circulation Research · doi:10.1161/01.res.80.6.877 · Cited by 258 · see citing works
Puntarulo, S., & Cederbaum, A. I. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00463-2 · Cited by 249 · see citing works
Flow-Induced Dilation of Human Coronary Arterioles
Miura, H., Wachtel, R. E., Liu, Y.-P., Loberiza, F. R., Saito, T., Miura, M., & Gutterman, D. D. (2001) · Circulation · doi:10.1161/01.cir.103.15.1992 · Cited by 249 · see citing works
Dickmann, L. J., Rettie, A. E., Kneller, M. B., Kim, R. B., Wood, A. J. J., Stein, C. M., Wilkinson, G. R., & Schwarz, U. I. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.382 · Cited by 249 · see citing works
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension
Holla, V. R., Adas, F., Imig, J. D., Zhao, X., Price, E., Olsen, N. J., Kovacs, W. J., Magnuson, M. A., Keeney, D. S., Breyer, M. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081627898 · Cited by 246 · see citing works
Coronary arteriolar myogenic response is independent of endothelium.
Kuo, L., Chilian, W. M., & Davis, M. J. (1990) · Circulation Research · doi:10.1161/01.res.66.3.860 · Cited by 239 · see citing works
Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species
Bondy, S. C., & Naderi, S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90235-6 · Cited by 237 · see citing works
Wang, M.-H., Brand‐Schieber, E., Zand, B. A., Nguyen, X., Falck, J. R., Balu, N., & Schwartzman, M. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37347-1 · Cited by 232 · see citing works
Wu, S., Chen, W., Murphy, E., Gabel, S. A., Tomer, K. B., Foley, J. F., Steenbergen, C., Falck, J. R., Moomaw, C. R., & Zeldin, D. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12551 · Cited by 227 · see citing works
Cytochrome P450: progress and predictions
Coon, M. J., Ding, X., Pernecky, S. J., & Vaz, A. D. N. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1537454 · Cited by 209 · see citing works
Human Coronary Arteriolar Dilation to Bradykinin Depends on Membrane Hyperpolarization
Miura, H., Liu, Y., & Gutterman, D. D. (1999) · Circulation · doi:10.1161/01.cir.99.24.3132 · Cited by 202 · see citing works
Hishikawa, K., Oemar, B. S., Yang, Z., & Lüscher, T. F. (1997) · Circulation Research · doi:10.1161/01.res.81.5.797 · Cited by 200 · see citing works
Molecular Characterization of an Arachidonic Acid Epoxygenase in Rat Brain Astrocytes
Alkayed, N. J., Narayanan, J., Gebremedhin, D., Medhora, M. M., Roman, R. J., & Harder, D. R. (1996) · Stroke · doi:10.1161/01.str.27.5.971 · Cited by 197 · see citing works
Inhibition of 20-HETE Production Contributes to the Vascular Responses to Nitric Oxide
Alonso‐Galicia, M., Drummond, H. A., Reddy, K. K., Falck, J. R., & Roman, R. J. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.320 · Cited by 196 · see citing works
Hu, S., & Kim, H. S. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90805-r · Cited by 196 · see citing works
20-HETE and the kidney: resolution of old problems and new beginnings
McGiff, J. C., & Quilley, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r607 · Cited by 188 · see citing works
Bauersachs, J. K., Hecker, M., & Busse, R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17172.x · Cited by 187 · see citing works
Eicosanoid regulation of the renal vasculature
Imig, J. D. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.6.f965 · Cited by 183 · see citing works
Pulsatile Stretch Stimulates Superoxide Production in Human Aortic Endothelial Cells
Hishikawa, K., & Lüscher, T. F. (1997) · Circulation · doi:10.1161/01.cir.96.10.3610 · Cited by 182 · see citing works
CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
Nieto, N., Friedman, S. L., Greenwel, P., & Cederbaum, A. I. (1999) · Hepatology · doi:10.1002/hep.510300433 · Cited by 181 · see citing works
Pressure and flow‐dependent vascular tone
Bevan, J. A., & Laher, I. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.9.1860618 · Cited by 176 · see citing works
Transon, C., Leemann, T., & Dayer, P. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050094 · Cited by 173 · see citing works
Arima, S., Endo, Y., Yaoita, H., Omata, K., Ogawa, S., Tsunoda, K., Abe, M., Takeuchi, K., Abe, K., & Ito, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119829 · Cited by 171 · see citing works
Popp, R., Bauersachs, J. K., Hecker, M., Fleming, I., & Busse, R. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021801 · Cited by 171 · see citing works
Self-citationZou, A. P., Ma, Y., SUI, Z., de Montellano, P. R. O., Clark, J. E., Masters, B. S. S., & Roman, R. J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38498-3 · Cited by 169 · see citing works
Isolation of preferentially expressed genes in the kidneys of hypertensive rats.
Iwai, N., & Inagami, T. (1991) · Hypertension · doi:10.1161/01.hyp.17.2.161 · Cited by 168 · see citing works
Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
Chen, J., Capdevila, J. H., Zeldin, D. C., & Rosenberg, R. L. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.288 · Cited by 165 · see citing works
Harder, D. R., Lange, A. R., Gebremedhin, D., Birks, E. K., & Roman, R. J. (2008) · Journal of Vascular Research · doi:10.1159/000159228 · Cited by 164 · see citing works
Sun, C., Alonso‐Galicia, M., Taheri, M. R., Falck, J. R., Harder, D. R., & Roman, R. J. (1998) · Circulation Research · doi:10.1161/01.res.83.11.1069 · Cited by 164 · see citing works
Cytochrome P-450 may link intracellular Ca2+ stores with plasma membrane Ca2+ influx
Álvarez, J., Montero, M., & Garcı́a-Sancho, J. (1991) · Biochemical Journal · doi:10.1042/bj2740193 · Cited by 163 · see citing works
Miura, H., & Gutterman, D. D. (1998) · Circulation Research · doi:10.1161/01.res.83.5.501 · Cited by 156 · see citing works
Nguyen, X., Wang, M.-H., Reddy, K. M., Falck, J. R., & Schwartzman, M. L. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.6.r1691 · Cited by 155 · see citing works
Nowicki, S., Chen, S. L., Aizman, O., Cheng, X.-J., Li, D., Nowicki, C., Nairn, A. C., Greengard, P., & Aperia, A. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119279 · Cited by 153 · see citing works
Role of CYP2C9 polymorphism in losartan oxidation.
Yaşar, Ü., Tybring, G., Hidestrand, M., Oscarson, M., Ingelman‐Sundberg, M., Dahl, M. L., & Eliasson, E. (2001) · PubMed · Cited by 152 · see citing works
Karara, A., Dishman, E., Falck, J. R., & Capdevila, J. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89484-8 · Cited by 147 · see citing works
Angiotensin II releases 20-HETE from rat renal microvessels
Croft, K. D., McGiff, J. C., Sánchez-Mendoza, A., & Carroll, M. A. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f544 · Cited by 146 · see citing works
Alkayed, N. J., Birks, E. K., Narayanan, J., Petrie, K. A., Kohler-Cabot, A. E., & Harder, D. R. (1997) · Stroke · doi:10.1161/01.str.28.5.1066 · Cited by 144 · see citing works
EET homologs potently dilate coronary microvessels and activate BKCachannels
Zhang, Y., Oltman, C. L., Lü, T., Lee, H.-C., Dellsperger, K. C., & VanRollins, M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.6.h2430 · Cited by 144 · see citing works
Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450
Sai, Y., Dai, R., Yang, T. J., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Shou, M. (2000) · Xenobiotica · doi:10.1080/004982500237541 · Cited by 138 · see citing works
Inoue, K., Yamazaki, H., Imiya, K., Akasaka, S., Guengerich, F. P., & Shimada, T. (1997) · Pharmacogenetics · doi:10.1097/00008571-199704000-00003 · Cited by 135 · see citing works
Chen, J., Falck, J. R., Reddy, K. M., Capdevila, J. H., & Harris, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29254 · Cited by 133 · see citing works
Munzenmaier, D. H., & Harder, D. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1163 · Cited by 131 · see citing works
Potentiation of Endothelium-Dependent Relaxation by Epoxyeicosatrienoic Acids
Weintraub, N. L., Fang, X., Kaduce, T. L., VanRollins, M., Chatterjee, P., & Spector, A. A. (1997) · Circulation Research · doi:10.1161/01.res.81.2.258 · Cited by 128 · see citing works
Fißlthaler, B., Hinsch, N., Chataigneau, T., Popp, R., Kiss, L., Busse, R., & Fleming, I. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.270 · Cited by 128 · see citing works
Self-citationHolla, V. R., Makita, K., Zaphiropoulos, P. G., & Capdevila, J. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7013 · Cited by 125 · see citing works
Renal And Cardiovascular Actions Of 20‐Hydroxyeicosatetraenoic Acid And Epoxyeicosatrienoic Acids
Roman, R. J., Maier, K. G., Sun, C., Harder, D. R., & Alonso‐Galicia, M. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03349.x · Cited by 124 · see citing works
Mancy, A., Dijols, S., Poli, S. M., Guengerich, F. P., & Mansuy, D. (1996) · Biochemistry · doi:10.1021/bi961950t · Cited by 123 · see citing works
Taddei, S., Ghiadoni, L., Virdis, A., Buralli, S., & Salvetti, A. (1999) · Circulation · doi:10.1161/01.cir.100.13.1400 · Cited by 122 · see citing works
Imig, J. D., Falck, J. R., Wei, S., & Capdevila, J. H. (2001) · Journal of Vascular Research · doi:10.1159/000051053 · Cited by 122 · see citing works
Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.
Roman, R. J., Ma, Y., Frohlich, B. H., & Markham, B. E. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.985 · Cited by 121 · see citing works
Su, P., Kaushal, K. M., & Kroetz, D. L. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.2.r426 · Cited by 119 · see citing works
Li, P., Cai-lian, C., Bortell, R., & Campbell, W. B. (1999) · Circulation Research · doi:10.1161/01.res.85.4.349 · Cited by 117 · see citing works
Cytochrome P450‐dependent effects of bradykinin in the rat heart
Fulton, D. J., Mahboubi, K., McGiff, J. C., & Quilley, J. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14911.x · Cited by 117 · see citing works
Pulsatile Stretch in Coronary Arteries Elicits Release of Endothelium-Derived Hyperpolarizing Factor
Popp, R., Fleming, I., & Busse, R. (1998) · Circulation Research · doi:10.1161/01.res.82.6.696 · Cited by 116 · see citing works
Self-citationInhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow
Alkayed, N. J., Birks, E. K., Hudetz, A. G., Roman, R. J., Henderson, L., & Harder, D. R. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.4.h1541 · Cited by 113 · see citing works
Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR
Omata, K., Abraham, N. G., & Schwartzman, M. L. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.262.4.f591 · Cited by 112 · see citing works
Chen, J., Wang, D. W., Falck, J. R., Capdevila, J. H., & Harris, R. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4764 · Cited by 111 · see citing works
Scarborough, P. E., Ma, J., Qu, W., & Zeldin, D. C. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101915 · Cited by 110 · see citing works
Juncos, L. A., Garvin, J., Carretero, O. A., & Ito, S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117977 · Cited by 109 · see citing works
CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR
Wang, M.-H., Zhang, F., Marji, J. S., Zand, B. A., Nasjletti, A., & Schwartzman, M. L. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.1.r255 · Cited by 109 · see citing works
In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation
Nishikawa, Y., Stepp, D. W., & Chilian, W. M. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h1252 · Cited by 108 · see citing works
Fleming, I., Fißlthaler, B., Michaelis, R., Kiss, L., Popp, R., & Busse, R. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100565 · Cited by 106 · see citing works
Self-citationKarara, A., Wei, S., Spady, D. K., Swift, L. L., Capdevila, J. H., & Falck, J. R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91877-s · Cited by 106 · see citing works
Cytochrome P450 metabolites of arachidonic acid in the control of renal function
Maier, K. G., & Roman, R. J. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200101000-00013 · Cited by 104 · see citing works
Bolz, S., Fißlthaler, B., Pieperhoff, S., de Wit, C., Fleming, I., Busse, R., & Pohl, U. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.255 · Cited by 103 · see citing works
Self-citationLocalization of cytochromeP-450 4A isoforms along the rat nephron
Ito, O., Alonso‐Galicia, M., Hopp, K. A., & Roman, R. J. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.2.f395 · Cited by 103 · see citing works
Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries
Sun, C., Falck, J. R., Okamoto, H., Harder, D. R., & Roman, R. J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.1.h339 · Cited by 100 · see citing works
14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells.
VanRollins, M., Kaduce, T. L., Knapp, H. R., & Spector, A. A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35111-7 · Cited by 100 · see citing works
Imig, J. D., Inscho, E. W., Deichmann, P. C., Reddy, K. M., & Falck, J. R. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.408 · Cited by 98 · see citing works
Omata, K., Abraham, N. G., Escalante, B., & Schwartzman, M. L. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.262.1.f8 · Cited by 98 · see citing works
Fang, X., Kaduce, T. L., Weintraub, N. L., VanRollins, M., & Spector, A. A. (1996) · Circulation Research · doi:10.1161/01.res.79.4.784 · Cited by 96 · see citing works
Jacobs, E. R., & Zeldin, D. C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.1.h1 · Cited by 96 · see citing works
Gruenke, L. D., Konopka, K., Cadieu, M., & Waskell, L. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24707 · Cited by 92 · see citing works
Yu, Z., Huse, L. M., Adler, P. B., Graham, L., Ma, J., Zeldin, D. C., & Kroetz, D. L. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26512-3 · Cited by 91 · see citing works
Is EDHF an epoxyeicosatrienoic acid?
Quilley, J., & McGiff, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01445-0 · Cited by 89 · see citing works
Imig, J. D., Falck, J. R., & Inscho, E. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702662 · Cited by 87 · see citing works
Identification of Arachidonate P-450 Metabolites in Human Platelet Phospholipids
Zhu, Y., Eb, S., McGiff, J. C., & Balazy, M. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.854 · Cited by 87 · see citing works
High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population.
García‐Martín, E., Martínez, C., Ladero, J. M., Garcia-Gamito, F. J., & Agúndez, J. A. G. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100264 · Cited by 87 · see citing works
VanRollins, M., Kaduce, T. L., Fang, X., Knapp, H. R., & Spector, A. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14001 · Cited by 82 · see citing works
Wong, P. Y.-K., Lai, P.-S., & Falck, J. R. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00079-4 · Cited by 82 · see citing works
Removal of Glutathione Produces Apoptosis and Necrosis in HepG2 Cells Overexpressing CYP2E1
Wu, D., & Cederbaum, A. I. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02259.x · Cited by 80 · see citing works
Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta
Pfister, S. M., Falck, J. R., & Campbell, W. B. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.3.h843 · Cited by 80 · see citing works
Widstrom, R. L., Norris, A. W., & Spector, A. A. (2001) · Biochemistry · doi:10.1021/bi001602y · Cited by 78 · see citing works
Weintraub, N. L., Fang, X., Kaduce, T. L., VanRollins, M., Chatterjee, P., & Spector, A. A. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.5.h2098 · Cited by 76 · see citing works
Cytochrome P-450 Metabolites Mediate Norepinephrine-Induced Mitogenic Signaling
Uddin, M. R., Muthalif, M. M., Karzoun, N. A., Benter, I. F., & Malik, K. U. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.242 · Cited by 71 · see citing works
Karara, A., Dishman, E., Jacobson, H., Falck, J. R., & Capdevila, J. H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81014-f · Cited by 70 · see citing works
Moreno, C. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02075-1 · Cited by 70 · see citing works
Microsomal monooxygenase in apoptosis: another target for cytochrome c signaling?
Davydov, D. R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01749-7 · Cited by 67 · see citing works
Malmsjö, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00062-0 · Cited by 67 · see citing works
Myogenic Responses Are Independent of the Endothelium in Rat Pressurized Posterior Cerebral Arteries
McCarron, J. G., Osol, G., & Halpern, W. (2008) · Blood Vessels · doi:10.1159/000158780 · Cited by 63 · see citing works
Gene Structure and Upstream Regulatory Regions of Human CYP2C9 and CYP2C18
Demorais, S. M. F., Schweikl, H., Blaisdell, J. A., & Goldstein, J. A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1803 · Cited by 63 · see citing works
Oyekan, A., McAward, K., Conetta, J. A., Rosenfeld, L., & McGiff, J. C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.3.r766 · Cited by 61 · see citing works
Oyekan, A., & McGiff, J. C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702171 · Cited by 60 · see citing works
Developmentally Regulated Expression of the CYP4AGenes in the Spontaneously Hypertensive Rat Kidney
Kroetz, D. L., Huse, L. M., Thuresson, A., & Grillo, M. P. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.362 · Cited by 60 · see citing works
Pohl, U., Lamontagne, D., Bassenge, E., & Busse, R. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.3.414 · Cited by 59 · see citing works
Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs
Pratt, P. F., Li, P., Hillard, C. J., Kurian, J., & Campbell, W. B. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h1113 · Cited by 59 · see citing works
Frisbee, J. C., Falck, J. R., & Lombard, J. H. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.5.h1517 · Cited by 58 · see citing works
Role of Cytochrome P-450 in Elevating Renal Vascular Tone in Spontaneously Hypertensive Rats
Gebremedhin, D., Ma, Y., Imig, J. D., Harder, D. R., & Roman, R. J. (2008) · Journal of Vascular Research · doi:10.1159/000158975 · Cited by 53 · see citing works
Fulton, D. J., McGiff, J. C., & Quilley, J. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37819-x · Cited by 53 · see citing works
Hashimoto, Y., OTSUKI, Y., ODANI, A., Takano, M., Hattori, H., Furusho, K., & Inui, K. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1103 · Cited by 51 · see citing works
Chen, J.-K., Capdevila, J. H., & Harris, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13789 · Cited by 50 · see citing works
Myogenic activation of canine small renal arteries after nonchemical removal of the endothelium
Liu, Y., Harder, D. R., & Lombard, J. H. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.1.h302 · Cited by 49 · see citing works
Chu, Z. M., Croft, K. D., KINGSBURY, D. A., Falck, J. R., REDDY, K. M., & Beilin, L. J. (2000) · Clinical Science · doi:10.1042/cs0980277 · Cited by 48 · see citing works
Cells in culture from rabbit medullary thick ascending limb of Henle's loop
Drugge, E. D., Carroll, M. A., & McGiff, J. C. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.5.c1070 · Cited by 46 · see citing works
Shivachar, A. C., Willoughby, K. A., & Ellis, E. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010338.x · Cited by 45 · see citing works
Balazy, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54320-9 · Cited by 44 · see citing works
Fang, X., Kaduce, T. L., Weintraub, N. L., & Spector, A. A. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90412-9 · Cited by 43 · see citing works
Molecular mechanisms controlling nutritive blood flow: role of cytochrome P450 enzymes
Harder, D. R., Roman, R. J., & Gebremedhin, D. (2000) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2000.00707.x · Cited by 43 · see citing works
Capdevila, J. H., Kishore, V., Dishman, E., Blair, I. A., & Falck, J. R. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90576-6 · Cited by 42 · see citing works
Joint Time and Time-Frequency Optimal Detection of K-Complexes in Sleep EEG
Richard, C., & Lengelle, R. (1998) · Computers and Biomedical Research · doi:10.1006/cbmr.1998.1476 · Cited by 39 · see citing works
Lin, J. H.-C., Kobari, Y., Zhu, Y., Stemerman, M. B., & Pritchard, K. A. (1996) · Endothelium · doi:10.3109/10623329609024698 · Cited by 34 · see citing works
Epoxyeicosatrienoic Acid–Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR
Pomposiello, S. I., Carroll, M. A., Falck, J. R., & McGiff, J. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.887 · Cited by 33 · see citing works
Role of guanylyl cyclase and cytochromeP-450 on renal response to nitric oxide
Andrade, B. L., Moreno, C., Salom, M. G., Roman, R. J., & Fenoy, F. J. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.3.f420 · Cited by 31 · see citing works
Muthalif, M. M., Uddin, M. R., Fatima, S., Parmentier, J., Khandekar, Z., & Malik, K. U. (2001) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(01)00112-5 · Cited by 30 · see citing works
Inhibition of renin release by 14,15-epoxyeicosatrienoic acid in renal cortical slices
Henrich, W., Falck, J. R., & Campbell, W. B. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.2.e269 · Cited by 25 · see citing works
Arachidonic acid metabolic pathways regulating activity of renal Na+-K+-ATPase are age dependent
Li, D., Belusa, R., Nowicki, S., & Aperia, A. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f823 · Cited by 24 · see citing works
BKCachannels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy
Clark, S. G., & Fuchs, L. C. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h2598 · Cited by 18 · see citing works
Oyekan, A., McAward, K., & McGiff, J. C. (1998) · PubMed · Cited by 16 · see citing works
Effect of aging on renal cytochrome P450-dependent arachidonic acid metabolism in Dahl rats.
Omata, K., TSUTSUMI, E., Sheu, H.-L., Utsumi, Y., & Abe, K. (1993) · PubMed · Cited by 11 · see citing works
CYTOCHROME P‐450‐DEPENDENT ARACHIDONATE METABOLITES AND RENAL FUNCTIONS IN THE LYON HYPERTENSIVE RAT
Messer-Létienne, I., Bernard, N., Benzoni, D., & Sassard, J. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02251.x · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Zhang Y, Oltman CL, Lu T, Lee HC, Dellsperger KC, VanRollins M. EET homologues potently dilate coronary microvessels and activate BK Ca channels. Am J Physiol Heart Circ Physiol. 2001;280: H2430 -H2440.
- Miura H, Gutterman DD. Human coronary arteriolar dilation to arachi- donic acid depends on cytochrome P-450 monoxygenase and Ca 2ϩ -ac- tivated K ϩ channels. Circ Res. 1998;83:501-507.
- Alvarez J, Montero M, García-Sancho J. Cytochrome P450 may link intracellular Ca 2ϩ stores with plasma membrane Ca 2ϩ influx. Biochem J. 1991;274:193-197.
- Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I. Nifedipine increases cytochrome P4502C expression and EDHF-mediated responses in coronary arteries. Hypertension. 2000;36: 270 -275.
Cited by
Sorted by citations
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,016 · see citing works
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
Watanabe, H., Vriens, J., Prenen, J., Droogmans, G., Voets, T., & Nilius, B. (2003) · Nature · doi:10.1038/nature01807 · Cited by 1,030 · see citing works
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
Li, J.-M., & Shah, A. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2004 · Cited by 773 · see citing works
Glial Cells Dilate and Constrict Blood Vessels: A Mechanism of Neurovascular Coupling
Metea, M. R., & Newman, E. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4048-05.2006 · Cited by 637 · see citing works
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
Allimuthu, D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01243 · Cited by 583 · see citing works
Mechanisms that regulate production of reactive oxygen species by cytochrome P450
Zangar, R. C. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.018 · Cited by 555 · see citing works
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
TRPV4 calcium entry channel: a paradigm for gating diversity
Nilius, B., Vriens, J., Prenen, J., Droogmans, G., & Voets, T. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00365.2003 · Cited by 492 · see citing works
EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological Roles
Morisseau, C. H. P., & Hammock, B. D. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095920 · Cited by 482 · see citing works
Action of epoxyeicosatrienoic acids on cellular function
Spector, A. A., & Norris, A. W. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2006 · Cited by 480 · see citing works
Epoxide hydrolases: their roles and interactions with lipid metabolism
Newman, J. W. I., Morisseau, C. H. P., & Hammock, B. D. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.10.001 · Cited by 476 · see citing works
REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
Aitken, A. E., Richardson, T. A., & Morgan, E. T. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141059 · Cited by 449 · see citing works
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_7 · Cited by 408 · see citing works
Vriens, J., Owsianik, G., Fißlthaler, B., Suzuki, M., Janssens, A., Voets, T., Morisseau, C. H. P., Hammock, B. D., Fleming, I., Busse, R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000187474.47805.30 · Cited by 365 · see citing works
Self-citationEpoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology
Imig, J. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00021.2011 · Cited by 363 · see citing works
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P. H., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 339 · see citing works
Astrocyte control of the cerebrovasculature
Gordon, G. R., Mulligan, S. J., & MacVicar, B. A. (2007) · Glia · doi:10.1002/glia.20543 · Cited by 323 · see citing works
Kunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302 · see citing works
Macrophage Differentiation to Foam Cells
Shashkin, P. N., Dragulev, B. P., & Ley, K. F. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054865064 · Cited by 291 · see citing works
Jiang, J.-G., Chun-lian, C. H. E. N., Card, J. W., Yang, S., Chen, J.-X., Fu, X.-N., Ning, Y.-G., Xiao, X., Zeldin, D. C., & Wang, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4173 · Cited by 284 · see citing works
Nitric oxide, oxidative stress, and progression of chronic renal failure
Modlinger, P., Wilcox, C. S., & Aslam, S. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.04.007 · Cited by 283 · see citing works
NADPH oxidase and endothelial cell function
Ray, R., & Shah, A. M. (2005) · Clinical Science · doi:10.1042/cs20050067 · Cited by 278 · see citing works
Bivalacqua, T. J., Usta, M. F., Champion, H. C., Kadowitz, P. J., & Hellstrom, W. J. G. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02743.x · Cited by 269 · see citing works
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system
Miyata, N., & Roman, R. J. (2005) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.41.175 · Cited by 239 · see citing works
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Xu, D., Li, N., He, Y., Timofeyev, V., Lü, L., Tsai, H.-J., Kim, I.-H., Tuteja, D., Mateo, R. K. P., Singapuri, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609158103 · Cited by 235 · see citing works
Griffith, T. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705698 · Cited by 234 · see citing works
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Imig, J. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00350.2004 · Cited by 232 · see citing works
Wang, Y., Wei, X., Xiao, X., Hui, R., Card, J. W., Carey, M. A., Wang, D. W., & Zeldin, D. C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083477 · Cited by 205 · see citing works
Cytochrome P450 pathways of arachidonic acid metabolism
Kroetz, D. L., & Zeldin, D. C. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00007 · Cited by 193 · see citing works
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189 · see citing works
Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer
Zhang, G., Kodani, S. D., & Hammock, B. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.11.003 · Cited by 189 · see citing works
Gomez, G. A., Morisseau, C. H. P., Hammock, B. D., & Christianson, D. W. (2004) · Biochemistry · doi:10.1021/bi036189j · Cited by 187 · see citing works
The contribution of astrocytes to the regulation of cerebral blood flow
Howarth, C. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00103 · Cited by 187 · see citing works
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Zhang, J., Duan, D., Song, Z., Liu, T., Hou, Y., & Fang, J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21734 · Cited by 184 · see citing works
Chuang, S. S., Helvig, C. F., Taimi, M., Ramshaw, H., Collop, A. H., Amad, M., White, J. A., Petkovich, M. P., Jones, G., & Korczak, B. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311830200 · Cited by 182 · see citing works
Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced Hypertension
Jung, O., Brandes, R. P., Kim, I.-H., Schweda, F., Schmidt, R., Hammock, B. D., Busse, R., & Fleming, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000153792.29478.1d · Cited by 180 · see citing works
Self-citationThe Soluble Epoxide Hydrolase as a Pharmaceutical Target for Hypertension
Chiamvimonvat, N., Ho, C.-M., Tsai, H.-J., & Hammock, B. D. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181506445 · Cited by 177 · see citing works
Michaelis, U. R., Fißlthaler, B., Barbosa‐Sicard, E., Falck, J. R., Fleming, I., & Busse, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02674 · Cited by 173 · see citing works
Self-citationSun, J., Sui, X., Bradbury, J. A., Zeldin, D. C., Conte, M. S., & Liao, J. K. (2002) · Circulation Research · doi:10.1161/01.res.0000017727.35930.33 · Cited by 171 · see citing works
Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies
Jones, P. D., Wolf, N. M., Morisseau, C. H. P., Whetstone, P. A., Hock, B., & Hammock, B. D. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.041 · Cited by 169 · see citing works
Michaelis, U. R., Fißlthaler, B., Medhora, M. M., Harder, D. R., Fleming, I., & Busse, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0640fje · Cited by 169 · see citing works
Self-citationReduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors
Granville, D. J., Tashakkor, B., Takeuchi, C., Gustafsson, Å. B., Huang, C., Sayen, M. R., Wentworth, P., Yeager, M., & Gottlieb, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308185100 · Cited by 167 · see citing works
Dhanasekaran, A., Gruenloh, S. K., Buonaccorsi, J. N., Zhang, R., Gross, G. J., Falck, J. R., Patel, P. K., Jacobs, E. R., & Medhora, M. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00979.2007 · Cited by 164 · see citing works
Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular Tissues
DeLozier, T. C., Kissling, G. E., Coulter, S. J., Dai, D., Foley, J. F., Bradbury, J. A., Murphy, E., Steenbergen, C., Zeldin, D. C., & Goldstein, J. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012823 · Cited by 163 · see citing works
Potente, M., Fißlthaler, B., Busse, R., & Fleming, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305385200 · Cited by 155 · see citing works
Self-citationSuematsu, M., Suzuki, H., DeLano, F. A., & Schmid‐Schönbein, G. W. (2002) · Microcirculation · doi:10.1038/sj.mn.7800141 · Cited by 155 · see citing works
Mammalian cytochromes P450—Importance of tissue specificity
Seliškar, M., & Rozman, D. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.016 · Cited by 154 · see citing works
Liu, Y., Terata, K., Chai, Q., Li, H., Kleinman, L. H., & Gutterman, D. D. (2002) · Circulation Research · doi:10.1161/01.res.0000046003.14031.98 · Cited by 154 · see citing works
Seet, R. C. S., Lee, J. C., Loke, W. M., Huang, S. H., Huang, H.-W., Looi, W. F., Chew, S. E., Quek, A. M. L., Lim, E. C. H., & Halliwell, B. B. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.019 · Cited by 152 · see citing works
Ward, N. C., Tsai, I.-J., Barden, A. E., BOCKXMEER, F. M. V., Puddey, I. B., Hodgson, J. M., & Croft, K. D. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.104463 · Cited by 149 · see citing works
Cytochrome P450 epoxygenases as EDHF synthase(s)
Fleming, I. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.016 · Cited by 145 · see citing works
Self-citationSchwarz, D., Kisselev, P., Ericksen, S. S., Szklarz, G. D., Chernogolov, A. A., Honeck, H., Schunck, W., & Roots, I. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.023 · Cited by 142 · see citing works
Fichtlscherer, S., Dimmeler, S., Breuer, S., Busse, R., Zeiher, A. M., & Fleming, I. (2003) · Circulation · doi:10.1161/01.cir.0000105763.51286.7f · Cited by 128 · see citing works
Self-citationTang, Y., Scheef, E. A., Wang, S., Sorenson, C. M., Marcus, C. B., Jefcoate, C. R. E., & Sheibani, N. (2008) · Blood · doi:10.1182/blood-2008-03-145219 · Cited by 127 · see citing works
Michaelis, U. R., & Fleming, I. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.003 · Cited by 127 · see citing works
Self-citationBlanco‐Rivero, J., Cachofeiro, V., Lahera, V., Aras‐López, R., Márquez‐Rodas, I., Salaíces, M., Xavier, F. E., Ferrer, M., & Balfagón, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000171479.36880.17 · Cited by 126 · see citing works
The Transcriptional Regulation of the Human CYP2C Genes
Chen, Y., & Goldstein, J. A. (2009) · Current Drug Metabolism · doi:10.2174/138920009789375397 · Cited by 125 · see citing works
GROSS, G., Falck, J. R., Gross, E. R., Isbell, M. A., MOORE, J., & Nithipatikom, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.007 · Cited by 125 · see citing works
Coleman, H. A., Tare, M., & Parkington, H. C. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.04053.x · Cited by 121 · see citing works
Bidirectional control of arteriole diameter by astrocytes
Gordon, G. R., Howarth, C., & MacVicar, B. A. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053132 · Cited by 118 · see citing works
Saraswathi, V., Hammock, B. D., Newman, J. W. I., Meerarani, P., Toborek, M. J., & Hennig, B. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719328 · Cited by 118 · see citing works
Pokreisz, P., Fleming, I., Kiss, L., Barbosa‐Sicard, E., Fißlthaler, B., Falck, J. R., Hammock, B. D., Kim, I.-H., Szelid, Z., Vermeersch, P., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000208299.62535.58 · Cited by 117 · see citing works
Self-citationUrinary 20-Hydroxyeicosatetraenoic Acid Is Associated With Endothelial Dysfunction in Humans
Ward, N. C., Rivera, J., Hodgson, J. M., Puddey, I. B., Beilin, L. J., Falck, J. R., & Croft, K. D. (2004) · Circulation · doi:10.1161/01.cir.0000136808.72912.d9 · Cited by 116 · see citing works
Zhang, L.-N., Vincelette, J., Cheng, Y., Mehra, U., Chen, D., Anandan, S., Gless, R. D., Webb, H. K., & Wang, Y. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186064 · Cited by 115 · see citing works
Inhibition of Cytochrome P450ω-Hydroxylase
Nithipatikom, K., Gross, E. R., Endsley, M. P., Moore, J. M., Isbell, M. A., Falck, J. R., Campbell, W. B., & Gross, G. J. (2004) · Circulation Research · doi:10.1161/01.res.0000146277.62128.6f · Cited by 115 · see citing works
Potente, M., Michaelis, U. R., Fißlthaler, B., Busse, R., & Fleming, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110806200 · Cited by 112 · see citing works
Self-citationAdventures in vascular biology: a tale of two mediators
Moncada, S. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1775 · Cited by 109 · see citing works
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction
Yasar, ?., Bennet, A. M., Eliasson, E., Lundgren, S., Wiman, B., Fairé, U. D., & Rane, A. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00002 · Cited by 111 · see citing works
Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1
Karlgren, M., Gomez, A. V., Stark, K., Svärd, J., Rodríguez‐Antona, C., Oliw, E. H., Bernal, M. L., y Cajal, S. R., Johansson, I., & Ingelman‐Sundberg, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.200 · Cited by 110 · see citing works
Popp, R., Brandes, R. P., Ott, G., Busse, R., & Fleming, I. (2002) · Circulation Research · doi:10.1161/01.res.0000015328.20581.d6 · Cited by 107 · see citing works
Self-citationEndothelium-Derived Hyperpolarizing Factor and Vascular Function
Ozkor, M. A., & Quyyumi, A. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/156146 · Cited by 104 · see citing works
Gomez, G. A., Morisseau, C. H. P., Hammock, B. D., & Christianson, D. W. (2005) · Protein Science · doi:10.1110/ps.051720206 · Cited by 101 · see citing works
The placental pursuit for an adequate oxidant balance between the mother and the fetus
Herrera, E. A., Krause, B. J., Ebensperger, G., Reyes, R. V., Casanello, P. C., Parra-Cordero, M., & Llanos, A. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00149 · Cited by 100 · see citing works
Rifkind, A. B. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570107 · Cited by 99 · see citing works
The emerging role of oxylipins in thrombosis and diabetes
Tourdot, B. E., Ahmed, I., & Holinstat, M. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00176 · Cited by 98 · see citing works
Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Goncharov, N. V., Avdonin, P. V., Nadeev, A. D., Zharkikh, I. L., & Jenkins, R. O. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141014142557 · Cited by 97 · see citing works
Cytochrome P450: major player in reperfusion injury
Gottlieb, R. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.004 · Cited by 96 · see citing works
Mitochondrial dysfunction in glaucoma: Understanding genetic influences
Lascaratos, G., Garway‐Heath, D. F., Willoughby, C. E., Chau, K., & Schapira, A. H. V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.004 · Cited by 96 · see citing works
Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily
Barbosa‐Sicard, E., Markovic, M., Honeck, H., Christ, B., Müller, D. N., & Schunck, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.103 · Cited by 93 · see citing works
The expansive role of oxylipins on platelet biology
Yeung, J., Hawley, M., & Holinstat, M. A. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1542-4 · Cited by 92 · see citing works
Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase Inhibitors
Imig, J. D. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00169.x · Cited by 90 · see citing works
Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death
Posadino, A. M., Cossu, A., Giordo, R., Zinellu, A., Sotgia, S., Vardeu, A., Hoa, P. T., Nguyen, L. H. V., Carru, C., & Pintus, G. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.01.017 · Cited by 89 · see citing works
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics
Imig, J. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.015 · Cited by 89 · see citing works
Nakao, A., Faleo, G., Shimizu, H., Nakahira, K., Kohmoto, J., Sugimoto, R., Choi, A. M. K., McCurry, K. R., Takahashi, T., & Murase, N. (2008) · Kidney International · doi:10.1038/ki.2008.342 · Cited by 88 · see citing works
Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function
Imig, J. D. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.04.003 · Cited by 86 · see citing works
Griffith, T. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.014 · Cited by 85 · see citing works
Imaoka, S., Hashizume, T., & Funae, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.478 · Cited by 83 · see citing works
The molecular sources of reactive oxygen species in hypertension
Puddu, P., Puddu, G. M., Cravero, E., Rosati, M., & Muscari, A. (2008) · Blood Pressure · doi:10.1080/08037050802029954 · Cited by 82 · see citing works
Local Regulation of Microvascular Perfusion
Davis, M. J., Hill, M. A., & Kuo, L. (2008) · Microcirculation · doi:10.1016/b978-0-12-374530-9.00006-1 · Cited by 78 · see citing works
Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids
Rand, A. A., Barnych, B. B., Morisseau, C. H. P., Čajka, T., Lee, K. S. S., Panigrahy, D., & Hammock, B. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616893114 · Cited by 76 · see citing works
Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
Michaud, V., Frappier, M., Dumas, M.-C., & Turgeon, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015666 · Cited by 75 · see citing works
Miller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 75 · see citing works
Chiu, P. Y., & Ko, K. M. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000049151.79238.30 · Cited by 74 · see citing works
Thum, T., & Borlak, J. T. (2003) · Circulation Research · doi:10.1161/01.res.0000110081.03480.e9 · Cited by 73 · see citing works
Rouhanizadeh, M., Hwang, J., Clempus, R. E., Marcu, L., Lassegue, B. P., Sevanian, A., & Hsiai, T. K. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.013 · Cited by 72 · see citing works
Michaelis, U. R., Falck, J. R., Schmidt, R., Busse, R., & Fleming, I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000151648.58516.eb · Cited by 72 · see citing works
Self-citationParkington, H. C., Chow, J. A. M., Evans, R. G., Coleman, H. A., & Tare, M. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021030 · Cited by 71 · see citing works
Soluble Epoxide Hydrolase in Atherosclerosis
Wang, Y.-X. J., Ulu, A., Zhang, L.-N., & Hammock, B. D. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0108-5 · Cited by 70 · see citing works
Estrogen, Aging and the Cardiovascular System
Stice, J. P., Lee, J. S., Pechenino, A. S., & Knowlton, A. A. (2008) · Future Cardiology · doi:10.2217/14796678.5.1.93 · Cited by 69 · see citing works
Ward, N. C., Croft, K. D., Blacker, D., Hankey, G. J., Barden, A. E., Mori, T. A., Puddey, I. B., & Etherton‐Beer, C. (2011) · Clinical Science · doi:10.1042/cs20110215 · Cited by 69 · see citing works
- Authors
- Fleming, I.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Fleming, Ingrid
- ORCID
- Fleming, Ingrid
- Venue
- Circulation Research
- Published
- 2001-10-26
- Volume
- 89
- Issue
- 9
- Pages
- 753-762
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2168349092
- Cited by
- 383
- References
- 142
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 8 · 2012: 13
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 553)
- Servier
- Institut de Recherches Servier
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- cytochrome P450, vascular homeostasis, arachidonic acid metabolism, epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, endothelial cells, vascular smooth muscle cells, vasodilation, vasoconstriction, myogenic response, reactive oxygen species, signal transduction, angiogenesis, hypertension, atherosclerosis, cardiovascular disease
- MeSH terms
- Animals, Biological Factors, Cardiovascular System, Cytochrome P-450 Enzyme System, Endothelium, Vascular, Epoxy Compounds, Free Radicals, Homeostasis, Humans, Hydroxyeicosatetraenoic Acids, Mixed Function Oxygenases, Isoenzymes, Muscle, Smooth, Vascular, Vasomotor System, 8,11,14-Eicosatrienoic Acid, Arachidonic Acid, Cytochrome P-450 CYP4A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review